FAQs
Medtronic stock has received a consensus rating of hold. The average rating score is and is based on 17 buy ratings, 23 hold ratings, and 3 sell ratings.
What is the future price of Medtronic stock? ›
MDT Stock 12 Month Forecast
Based on 15 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $95.00 with a high forecast of $110.00 and a low forecast of $76.00. The average price target represents a 16.36% change from the last price of $81.64.
Why is Medtronic dropping? ›
Shares of Medtronic PLC dropped Thursday, after the medical device and therapies company extended its streak of quarterly earnings beats for its fiscal fourth-quarter, but provided a disappointing outlook for the current quarter.
What will Medtronic stock price be in 2025? ›
Long-Term Medtronic Plc Stock Price Predictions
| Year | Prediction | Change |
|---|
| 2025 | $ 85.35 | 4.54% |
| 2026 | $ 89.23 | 9.30% |
| 2027 | $ 93.28 | 14.26% |
| 2028 | $ 97.52 | 19.45% |
2 more rowsMedtronic offers a growing dividend
At 3.4%, the yield is more than double the S&P 500 average of 1.4% and can be an excellent source of recurring income for investors. The healthcare company has also been increasing it for decades. And over the past five years, it has risen by 28%.
Who owns the most shares of Medtronic? ›
Largest shareholders include Vanguard Group Inc, BlackRock Inc., State Street Corp, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, VFINX - Vanguard 500 Index Fund Investor Shares, Jpmorgan Chase & Co, Capital Research Global Investors, Morgan Stanley, Geode Capital Management, Llc, and Massachusetts ...
Has Medtronic stock ever split? ›
Medtronic stock (symbol: MDT) underwent a total of 7 stock splits. The most recent stock split occurred on September 27th, 1999. One MDT share bought prior to August 1st, 1980 would equal to 128 MDT shares today.
Is Medtronic a blue chip stock? ›
Additionally, ongoing partnerships with Nvidia (NASDAQ:NVDA) keep Medtronic at the forefront of emerging health tech trends, solidifying its position as a top blue-chip stock to buy today.
Is Medtronic undervalued? ›
Furthermore, Medtronic's stock is considered undervalued by Petrone, who sees significant upside potential if the market reacts favorably to the company's FY25 guidance. The combination of near 5% expected top-line organic growth and adjusted EPS in line with or above consensus estimates reinforces the Buy thesis.
Is Medtronic in trouble? ›
Unfortunately, the company has battled multiple headwinds in recent times, which has led to uninspiring financials and a disappointing stock performance. In the past three years, shares of Medtronic have fallen by 24%.
In 2018, ICIJ's Implant Files investigation found that governments on four continents had accused Medtronic of promoting unauthorized uses of products, defrauding government health programs, price fixing, paying doctors for favorable studies and engaging in anti-competitive conduct.
Is Medtronic a good dividend stock? ›
Medtronic's dividend yields 3.4%, which is more than twice the S&P 500 average of 1.4%. It can be a reliable dividend stock to own.
Will Medtronic stock go up? ›
From a valuation perspective, we think it has some room for growth. We estimate Medtronic's Valuation to be $96 per share, reflecting an upside of over 10%. MDT stock currently trades at 17x expected earnings of $5.19 per share in 2024, lower than its 20x average over the last three years.
How often does Medtronic pay dividends? ›
Medtronic plc ( MDT ) pays dividends on a quarterly basis.
What is Medtronic stock forecast for 2024? ›
We estimate Medtronic's valuation to be $96 per share, reflecting an upside of over 15% from its current level of $83. Our forecast is based on a 19x P/E multiple for MDT and expected earnings of $5.19 on a per-share and adjusted basis for fiscal 2024.
